| Net Cash Provided by (Used in) Operating Activities |
$388,346,000 |
USD |
4.6% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$301,637,000 |
USD |
-186% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$102,200,000 |
USD |
84% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$15,491,000 |
USD |
-117% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$455,757,000 |
USD |
-2.1% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$927,304,000 |
USD |
13% |
Q4 2024 |
FY 2024 |
| Depreciation |
$1,208,820,000 |
USD |
7.7% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$72,871,000 |
USD |
-41% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$969,905,000 |
USD |
100% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$95,322,000 |
USD |
257% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$561,287,000 |
USD |
14% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
900,000 |
shares |
-92% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$3,392,298,000 |
USD |
-5.7% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
900,000 |
shares |
-92% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$738,980,000 |
USD |
27% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |